| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Amlexanox |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ketotifen fumarate |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pemirolast potassium |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lodoxamide (substance) |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing nedocromil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olopatadine (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing mast cell stabilizer (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cromoglicic acid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate [gastro-intestinal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cromoglicate sodium 100 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate [asthma] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate 20mg inhalation capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate 20mg/2mL nebulization unit (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate 5mg inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate 5mg inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate 5mg breath-actuated aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate compounds |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ketotifen [asthma prophylaxis] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ketotifen 1 milligram/1 each conventional release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ketotifen 1 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ketotifen 1mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nedocromil sodium [asthma] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely nedocromil sodium 2 milligram/1 actuation conventional release pressurized suspension for inhalation (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nedocromil sodium 2mg inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ketotifen [antihistamine] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nedocromil sodium [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nedocromil sodium 20 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter and xylometazoline hydrochloride 250 microgram/1 milliliter conventional release nasal spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nedocromil sodium [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate+isoprenaline sulfate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cromoglicate sodium and salbutamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate 2% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromoglycate and related antiallergenic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing sodium cromoglycate in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Inhaled sodium cromoglycate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing sodium cromoglycate in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ketotifen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 20mg/2 mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nedocromil sodium 2% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 0.8mg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nedocromil sodium 1.75mg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 20mg/amp solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglicate 40 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 100mg/5mL gas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olopatadine hydrochloride 0.1% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 5.2mg/spr solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 10mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 800mcg/inh |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 40mg/spr solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 8.1g spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 40mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 0.8mg/spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ophthalmic cromolyn sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ketotifen [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ketotifen 250micrograms/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate+xylometazoline hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ketotifen (as ketotifen fumarate) 250 microgram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olopatadine (as olopatadine hydrochloride) 1 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromolyn sodium 100mg/5ml oral concentrate solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nedocromil sodium 2% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pemirolast (substance) |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Olopatadine (as olopatadine hydrochloride) 2 mg/mL eye solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ketotifen in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing ketotifen in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cromoglicic acid (substance) |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nedocromil |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nedocromil sodium |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Lodoxamide trometamol (substance) |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglicate |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Adverse reaction to mast cell stabiliser |
Causative agent (attribute) |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ketotifen (substance) |
Is a |
True |
Substance with mast cell stabilizer mechanism of action (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]